In the News
Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.
MedCity News
|
April 5, 2026
Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics
Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral…
For more
CFO Brew
|
March 31, 2026
Pharma CFO plans for telehealth expansion
Sam Backenroth is concocting a recipe for Aspargo Labs’ finance function. Backenroth joined the company, which develops liquid oral suspensions…
For more
The Columbian
|
March 28, 2026
Vancouver-based CytoDyn makes waves in breast cancer treatment
Four short years ago, Vancouver-based CytoDyn was embroiled in scandal. But a group of executives fought to bring the biotech…
For more
JAMA
|
March 26, 2026
FDA’s Promising New Framework for Rare Genetic Diseases
The ability to treat the underlying causes of rare genetic diseases is a new scientific achievement after many years when…
For more
Axios
|
March 26, 2026
Pinnacle Medicines raises $89M for oral peptide development
Pinnacle Medicines, developer of oral peptides for immunology and cardiometabolic diseases, raised an $89 million Series B. Oral peptide drugs…
For more
ABC (WJBF-TV)
|
March 23, 2026
Augusta Fire Dept. holds esophageal pre-cancer screenings for firefighters, staff
Firefighters face many dangers when battling a blaze, including an increased risk of certain cancers. That’s why the Augusta Fire…
For more
FOX 26
|
March 20, 2026
Experimental cell therapy keeps Houston father of 3 diagnosed with aggressive malignant tumor alive
Glioblastoma, the most common malignant brain tumor, is among the deadliest cancers, with most patients facing extremely short survival timelines….
For more
NPR
|
March 18, 2026
Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s…
For more
The Scientist
|
February 7, 2026
From Discovery to Therapy: The Rise of Reprogrammed Tregs
Nobel Prize winner Shimon Sakaguchi, a pioneer in regulatory T cell (Treg) biology, discusses the path from early observations to…
For more
WGN-TV
|
February 5, 2026
New drug may help spinal cord injury patients regain function and hope
There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug,…
For more
Upcoming Events
Our team is active across the industry year-round. Find us at these upcoming conferences and events.
